The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >
Hybridization-based target enrichment panel with our intrinsic probe design, rebalancing, and molecular barcode technologies to efficiently analyze not only hard-to-capture areas but also challenging samples, such as damaged DNA or RNA.
View Detail >
End-to-end customized target enrichment panel with assay optimization, validation and even complete BI support. Over 1,000 custom panels developed world-wide. White-labeled customized product for business expansion also available.
View Detail >
The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >
The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >
End-to-end customized target enrichment panel with assay optimization, validation and even complete BI support. Over 1,000 custom panels developed world-wide. White-labeled customized product for business expansion also available.
View Detail >
Providing NGS-based diagnostics solutions for biopharma companies. Celemics can develop and deliver a flexible customization and commercialization services while maintaining the market-leading performance for our clients interested in clinical and companion diagnostics.
View Detail >
Tailored-fit customized assay development from designing to validation run; including not only the custom panel design but also species-specific or sequencer-specific blockers, followed by reagent conditioning to optimize the individual experiment and sequencer.
View Detail >
The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >
Find useful information, insights and tools for your Celemics’ products and services
View Detail >
Explore the most up-to-date publications featuring Celemics’ products and services
View Detail >
Sharing interesting stories about the world of NGS and how Celemics delivers the innovative NGS solutions to the world of science.
View Detail >
Explore a diverse range of engaging video content, from fascinating experiments showcasing cutting-edge research to heartfelt customer testimonials.
View Detail >
Find useful information, insights and tools for your Celemics’ products and services
View Detail >
Stay up-to-date with the latest updates on our activities, events and achievements
View Detail >
Let’s change the NGS market together – our global presence and partners world-wide
View Detail >
Waiting for your experience with Celemics, an innovative leader in NGS industry
View Detail >Oncology
Yonsei Medical Journal Implementation of a Targeted Next-Generation Sequencing Panel for Constitutional Newborn Screening in High-Risk Neonates Lee H, Lim J, Shin JE, Eun HS, Park MS, Park KI, et…
Clinical Cancer Research Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin Lee DW, Han SW, Bae JM, Jang H, Han H, Kim…
Annals of Human Genetics Impact of next‐generation sequencing panels in the evaluation of limb‐girdle muscular dystrophies Song HK, Sonkaria S, Khare V, Dong K, Lee HT, Ahn SH, et al.…
PloS one Telomere length and its correlation with gene mutations in chronic lymphocytic leukemia in a Korean population Song DY, Kim JA, Jeong D, Yun J, Kim SM, Lim K,…
Leukemia Research Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia Hwang SM, Kim SM, Nam Y, Kim J, Kim S, Ahn YO, et al. Targeted sequencing aids in…
BMC Medical Genomics Next-generation sequencing with comprehensive bioinformatics analysis facilitates somatic mosaic APC gene mutation detection in patients with familial adenomatous polyposis Kim B, Won D, Jang M, Kim H,…
PloS one Somatic mosaic truncating mutations of PPM1D in blood can result from expansion of a mutant clone under selective pressure of chemotherapy Kim B, Won D, Lee ST, Choi…
Leukemia & Lymphoma Clinical utility of targeted NGS panel with comprehensive bioinformatics analysis for patients with acute lymphoblastic leukemia Kim B, Lee H, Kim E, Shin S, Lee ST, Choi…
Transactions of the Royal Society of South Africa Neutral models predict biogeographical patterns of soil microbes at a local scale in Mediterranean heathlands, South Africa Moroenyane I, Chimphango SBM, Dong…
BMC Cancer Association of pathway mutation with survival after recurrence in colorectal cancer patients reated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy Lee DW, Han SW, Cha Y, Bae JM, Kim…
